Edit |   |
---|---|
Antigenic Specificity | CD20 + CD22 Tandem scFv-MEL (bispecific immunotoxin) |
Clone | monoclonal |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | n/a |
Format | bispecific immunotoxin |
Size | n/a |
Concentration | n/a |
Applications | FuncS; Promising therapeutic agent; |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Recombinant Anti-CD20 x Anti-CD22 Tandem scFv-MEL immunotoxin (Bispecific Immunotoxin). Recombinant Anti-CD20 x Anti-CD22 Tandem scFv-MEL immunotoxin (Bispecific Immunotoxin) is designed to be expressed as the Melittin (MEL) fused to a tandem scFv recognizing CD20 and CD22. It contains a His-tag at the C/N terminus for affinity purification. This bispecific immunotoxin can deliver MEL to antigen-specific cells. Then MEL is a cytolytic peptide and can kill the target cells. The bispecific immunotoxin is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy. |
Immunogen | n/a |
Other Names | MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1 |
Gene, Accession # | UniProt: A0A024R507 |
Catalog # | BSFV-MEL004 |
Price | please inquire |
Order / More Info | CD20 + CD22 Tandem scFv-MEL (bispecific immunotoxin) Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |